4//SEC Filing
O'Gorman Cedric 4
Accession 0001213900-23-002871
CIK 0001553643other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 5:54 PM ET
Size
5.4 KB
Accession
0001213900-23-002871
Insider Transaction Report
Form 4
O'Gorman Cedric
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2023-01-06−400,000→ 400,000 totalExercise: $3.29Exp: 2033-01-06→ Common stock (400,000 underlying)
Footnotes (1)
- [F1]The shares vest in 16 equal quarterly installments commencing on April 6, 2023.
Documents
Issuer
RELMADA THERAPEUTICS, INC.
CIK 0001553643
Entity typeother
Related Parties
1- filerCIK 0001962179
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 5:54 PM ET
- Size
- 5.4 KB